SIGNIFICANCE OF GENE AMPLIFICATIONS ON RELAPSE-FREE SURVIVAL (RFS) AND OVERALL SURVIVAL (OS) IN METASTATIC BREAST CANCER

被引：0
|
作者：
Todorovic-Rakovic, Natasa [1 ]
Neskovic-Konstantinovic, Zora [1 ]
Nikolic-Vukosavljevic, Dragica [1 ]
机构：
[1] Inst Oncol & Radiol Serbia, Belgrade, Serbia
来源：
BREAST | 2013年 / 22卷
关键词：
D O I：
10.1016/S0960-9776(13)70131-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S59 / S60
页数：2
相关论文
共 50 条
  • [1] A TRIM24-like mutational signature predicts worse relapse-free survival (RFS) and overall survival (OS) in patients (pts) with metaplastic breast cancer (MpBC)
    Yam, Clinton
    Duncan, Aundrietta
    Chang, Jeffrey T.
    Gilcrease, Michael Z.
    Shah, Vrutant V.
    Barton, Michelle
    Moulder, Stacy L.
    CANCER RESEARCH, 2018, 78 (13)
  • [2] Relapse-free survival (RFS) after surgical resection to predict survival after relapse (SAR) and overall survival (OS) in patients with pancreatic ductal adenocarcinoma (PDA).
    Rodriguez-Pascual, Jesus
    Alvarez-Gallego, Rafael
    Munoz, Cesar
    Ugidos, Lisardo
    Sanz, Enrique
    Ceniceros, Lucia
    Rivas, Maria
    Torres, Esther
    Cardenas, Jose M.
    Cubillo Gracian, Antonio
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer
    Andreas Varkaris
    Anastasia Katsiampoura
    Jennifer S. Davis
    Neeraj Shah
    Michael Lam
    Rosa Lizeth Frias
    Cristina Ivan
    Masayoshi Shimizu
    Jeffrey Morris
    David Menter
    Michael Overman
    Hai Tran
    John Heymach
    Yun Shin Chun
    Jean-Nicolas Vauthey
    George Calin
    Scott Kopetz
    British Journal of Cancer, 2019, 120 : 340 - 345
  • [4] Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer
    Varkaris, Andreas
    Katsiampoura, Anastasia
    Davis, Jennifer S.
    Shah, Neeraj
    Lam, Michael
    Frias, Rosa Lizeth
    Ivan, Cristina
    Shimizu, Masayoshi
    Morris, Jeffrey
    Menter, David
    Overman, Michael
    Tran, Hai
    Heymach, John
    Chun, Yun Shin
    Vauthey, Jean-Nicolas
    Calin, George
    Kopetz, Scott
    BRITISH JOURNAL OF CANCER, 2019, 120 (03) : 340 - 345
  • [5] Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258
    Clements, Aine
    Enserro, Danielle
    Strickland, Kyle C.
    Previs, Rebecca
    Matei, Daniela
    Mutch, David
    Powell, Matthew
    Klopp, Ann
    Miller, David Scott
    Small Jr, William
    Disilvestro, Paul
    Spirtos, Nick
    Cosgrove, Casey
    Sfakianos, Greg
    Liu, J. Rebecca
    Vargas, Roberto
    Shahin, Mark
    Corr, Bradley
    Dessources, Kimberly
    Ueland, Frederick
    Warshal, David
    Gillen, Jessica
    Secord, Angeles Alvarez
    GYNECOLOGIC ONCOLOGY, 2025, 193 : 119 - 129
  • [6] Clusterin Overexpression and Relapse-free Survival in Breast Cancer
    Yom, Cha Kyong
    Woo, Hee-Yeon
    Min, Sun Young
    Kang, So Young
    Kim, Hee Sung
    ANTICANCER RESEARCH, 2009, 29 (10) : 3909 - 3912
  • [7] Influence of Treatment Conforming to Guidelines on Recurrence Free Survival (RFS) and Overall Survival (OS) in Triple Negative Breast Cancer.
    Atassi, Z.
    Wischnewsky, M.
    Woeckel, A.
    Kurzeder, C.
    Wolters, R.
    Novopashenny, I
    Kreienberg, R.
    CANCER RESEARCH, 2009, 69 (24) : 625S - 626S
  • [8] RELAPSE-FREE SURVIVAL IS NOT A GOOD MEASUREMENT OF SURVIVAL IN BREAST-CANCER - REPLY
    STRENDER, LE
    WALLGREN, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (10): : 1815 - 1815
  • [9] Prognostic significance of post-treatment standardized uptake value (pSUV) of positron emission tomography (PET) to predict overall survival (OS) and relapse-free survival (RFS) in patients with esophageal or gastroesophageal cancer treated with definitive chemoradiotherapy
    Suzuki, A.
    Xiao, L.
    Hayashi, Y.
    Welsh, J.
    Lin, S. H.
    Maru, D.
    Hofstetter, W. L.
    Mehran, R. J.
    Lee, J. H.
    Bhutani, M. S.
    Macapinlac, H. A.
    Liao, Z. X.
    Ajani, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Evaluating relapse-free survival as an endpoint for overall survival in adjuvant immunotherapy trials
    Li, Yuanfang
    Yuan, Shuqiang
    Chen, Yingbo
    Nie, Man
    Li, Jibin
    Chen, Guoming
    Chen, Xiaojiang
    Zhang, Ruopeng
    Zheng, Ziqi
    Wei, Chengzhi
    Zhou, Zhiwei
    Nie, Runcong
    Wang, Yun
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (09): : 1085 - 1091
12345